184 related articles for article (PubMed ID: 9128837)
1. Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist.
Baron BM; Harrison BL; Kehne JH; Schmidt CJ; van Giersbergen PL; White HS; Siegel BW; Senyah Y; McCloskey TC; Fadayel GM; Taylor VL; Murawsky MK; Nyce P; Salituro FG
Eur J Pharmacol; 1997 Apr; 323(2-3):181-92. PubMed ID: 9128837
[TBL] [Abstract][Full Text] [Related]
2. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
[TBL] [Abstract][Full Text] [Related]
3. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats.
Millan MJ; Audinot V; Honoré P; Bervoets K; Veiga S; Brocco M
Eur J Pharmacol; 2000 Jan; 388(1):37-47. PubMed ID: 10657545
[TBL] [Abstract][Full Text] [Related]
4. MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profiles.
Kehne JH; Baron BM; Harrison BL; McCloskey TC; Palfreyman MG; Poirot M; Salituro FG; Siegel BW; Slone AL; Van Giersbergen PL
Eur J Pharmacol; 1995 Sep; 284(1-2):109-18. PubMed ID: 8549613
[TBL] [Abstract][Full Text] [Related]
5. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.
Parsons CG; Danysz W; Quack G; Hartmann S; Lorenz B; Wollenburg C; Baran L; Przegalinski E; Kostowski W; Krzascik P; Chizh B; Headley PM
J Pharmacol Exp Ther; 1997 Dec; 283(3):1264-75. PubMed ID: 9400002
[TBL] [Abstract][Full Text] [Related]
6. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
Baron BM; Harrison BL; McDonald IA; Meldrum BS; Palfreyman MG; Salituro FG; Siegel BW; Slone AL; Turner JP; White HS
J Pharmacol Exp Ther; 1992 Sep; 262(3):947-56. PubMed ID: 1388205
[TBL] [Abstract][Full Text] [Related]
7. Effects of RPR 118723, a novel antagonist at the glycine site of the NMDA receptor, in vitro.
Boireau A; Monterrat C; Bordier F; Meunier M; Imperato A
Eur J Pharmacol; 2000 Aug; 401(2):131-5. PubMed ID: 10924917
[TBL] [Abstract][Full Text] [Related]
8. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
Widdowson PS; Gyte AJ; Upton R; Wyatt I
Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
[TBL] [Abstract][Full Text] [Related]
9. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
10. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.
Carter CJ; Lloyd KG; Zivkovic B; Scatton B
J Pharmacol Exp Ther; 1990 May; 253(2):475-82. PubMed ID: 1971016
[TBL] [Abstract][Full Text] [Related]
11. [3H]MDL 105,519 binds with equal high affinity to both assembled and unassembled NR1 subunits of the NMDA receptor.
Chazot PL; Reiss C; Chopra B; Stephenson FA
Eur J Pharmacol; 1998 Jul; 353(1):137-40. PubMed ID: 9721050
[TBL] [Abstract][Full Text] [Related]
12. Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site.
Baron BM; Harrison BL; Miller FP; McDonald IA; Salituro FG; Schmidt CJ; Sorensen SM; White HS; Palfreyman MG
Mol Pharmacol; 1990 Oct; 38(4):554-61. PubMed ID: 2172769
[TBL] [Abstract][Full Text] [Related]
13. Amphetamine inhibits the N-methyl-D-aspartate receptor-mediated responses by directly interacting with the receptor/channel complex.
Yeh GC; Chen JC; Tsai HC; Wu HH; Lin CY; Hsu PC; Peng YC
J Pharmacol Exp Ther; 2002 Mar; 300(3):1008-16. PubMed ID: 11861810
[TBL] [Abstract][Full Text] [Related]
14. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
[TBL] [Abstract][Full Text] [Related]
15. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
Irifune M; Shimizu T; Nomoto M; Fukuda T
Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.
Ohtani K; Tanaka H; Yoneda Y; Yasuda H; Ito A; Nagata R; Nakamura M
Brain Res; 2002 Jul; 944(1-2):165-73. PubMed ID: 12106676
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 3-carboxy-5-phosphono-1,2,3,4-tetrahydroisoquinoline (SC-48981), a potent competitive N-methy-D-aspartate (NMDA) receptor antagonist, in vitro and in vivo.
Vazquez ML; Garland DJ; Sun ET; Cler JA; Mick SJ; Hood WF; Monahan JB; Iyengar S; Rao TS
Neurosci Lett; 1992 Feb; 135(2):149-52. PubMed ID: 1352628
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.
Bristow LJ; Hutson PH; Kulagowski JJ; Leeson PD; Matheson S; Murray F; Rathbone D; Saywell KL; Thorn L; Watt AP; Tricklebank MD
J Pharmacol Exp Ther; 1996 Nov; 279(2):492-501. PubMed ID: 8930150
[TBL] [Abstract][Full Text] [Related]
19. Complex polyamine effects on [3H]MDL 105,519 binding to the NMDA receptor glycine site.
Sharma TA; Reynolds IJ
Neurochem Int; 1998 Aug; 33(2):155-9. PubMed ID: 9761459
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits.
Smothers CT; Woodward JJ
J Pharmacol Exp Ther; 2007 Aug; 322(2):739-48. PubMed ID: 17502428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
